Phoenix Biotech Acquisition Corp.
NASDAQ:PBAX
5.85 (USD) • At close February 14, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Phoenix Biotech Acquisition Corp. |
Symbool | PBAX |
Munteenheid | USD |
Prijs | 5.85 |
Beurswaarde | 36,472,293 |
Dividendpercentage | 0% |
52-weken bereik | 4.12 - 12.8 |
Industrie | Shell Companies |
Sector | Financial Services |
CEO | Mr. Christopher B. Ehrlich M.B.A. |
Website | 0 |
An error occurred while fetching data.
Over Phoenix Biotech Acquisition Corp.
Phoenix Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It engages in identifying and acquiring a business that focuses on the healthcare or healthcare related industries in
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)